Vaxcyte, Inc. (PCVX) Reports In-Line Q1 EPS

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q1 EPS of ($1.04), in-line with the analyst estimate of ($1.04).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Freedom Broker Starts Holley (HLLY) at Buy
• Nasdaq moves to delist Pitanium Limited securities by July 16
• Penguin Solutions (PENG) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY26 EPS Guidance